Skip to main content
. Author manuscript; available in PMC: 2008 May 2.
Published in final edited form as: Arch Dermatol. 2007 Jan;143(1):21–28. doi: 10.1001/archderm.143.1.21

Figure 2.

Figure 2

Sensitivity analyses on the impact of the screening cost (A), the annual melanoma progression rate (B), and the specificity for melanoma detection by visual screening (C) on the cost-effectiveness of melanoma screening. CE indicates cost-effectiveness; QALY, quality-adjusted life year.